To report a case of eosinophilic myocarditis induced by dobutamine in a patient with cardiogenic shock, highlighting its clinical significance.
Key Findings:
Eosinophilic myocarditis can occur as a hypersensitivity reaction to dobutamine.
The patient required left ventricular assist device implantation due to refractory cardiogenic shock.
Corticosteroid therapy improved hemodynamics after discontinuation of dobutamine.
The patient's progression to left ventricular assist device implantation underscores the severity of the condition.
Interpretation:
Clinicians should consider drug-induced eosinophilic myocarditis in patients with refractory cardiogenic shock receiving dobutamine, as alternative inotropic agents may be safer. Monitoring eosinophil levels is crucial.
Limitations:
The case is based on a single patient experience, limiting generalizability.
Potential confounding factors in the patient's medical history may complicate the interpretation of causality.
Lack of long-term follow-up data limits understanding of outcomes.
Conclusion:
This case highlights the need for awareness of eosinophilic myocarditis as a potential adverse effect of dobutamine, advocating for careful monitoring and consideration of alternative therapies. Further research on drug-induced eosinophilic myocarditis is warranted.
by Abdullah Aljudaibi, Kristi Dutta, Sahitya Allam, Jose-Alejandro Almario, Lo Tamburro, Lynn Dees, Erik Sorensen, Bartley P. Griffith, Gautam Ramani, Manjula Ananthram